ACHE and dementia: For example, the administration of rivastigmine, a dual inhibitor of acetylcholinesterase and butyrylcholinesterase, demonstrated significantly greater responses of cognitive and behavioural functions in patients with dementia than the selective acetylcholinesterase inhibitors such as donepezil and galantamine (Ballard, 2002; Kandiah et al., 2017).